A Director at Tonix Pharma (NASDAQ: TNXP) is Selling Shares

By Carrie Williams

Today, a Director at Tonix Pharma (NASDAQ: TNXP), Ernest Mario, sold shares of TNXP for $129.8K.

The company has a one-year high of $9.40 and a one-year low of $2.85. Currently, Tonix Pharma has an average volume of 65.78K.

Ernest Mario’s trades have generated a -2.4% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company, which engages in the development of innovative pharmaceutical products to public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It also includes TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.